Status:
COMPLETED
Value of Butyrylcholinesterase as a Marker of Surgical Site Infection Following Surgery for Colorectal Diseases
Lead Sponsor:
University Hospital of Patras
Conditions:
Colorectal Disorders
Colorectal Neoplasms
Eligibility:
All Genders
18+ years
Brief Summary
Butyrylcholinesterase (BChE) is an α-glycoprotein synthesized in the liver. BchE's serum level decreases in many clinical conditions such as acute and chronic liver damage, inflammation, injury and in...
Detailed Description
Butyrylcholinesterase (BChE or BuChE) is a cholinesterase enzyme that is very similar to acetylcholinesterase (AChE). However, though the role and function of AChE in the human body are widely studied...
Eligibility Criteria
Inclusion
- Operation for colorectal disease
- Older than 18 years old
Exclusion
- Younger than 18 years old
Key Trial Info
Start Date :
November 6 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04748744
Start Date
November 6 2019
End Date
May 1 2023
Last Update
June 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Francesk Mulita
Pátrai, Achaia, Greece, 26223